Varda is designing and building the infrastructure needed to make low Earth orbit accessible, from in-orbit production equipment to reliable reentry capsules.
Today, we’re announcing Varda’s $250M Series D raise, bringing the total amount of capital raised to $598 million with a $1.6B valuation.
This funding will help us build more vehicles, grow pharmaceutical partnerships, and advance toward the first medicine manufactured in space for patients on Earth.